Skip to main content

LLY Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Eli Lilly and Company News

Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact

Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.

Cramer's Mad Money Recap 6/15: Powell Crushes it

Jim Cramer says the Fed action is great news for high-growth tech stocks, which should be among the first sectors to recover.

Cramer's Mad Money Recap 6/7: Target, Smucker, Eli Lilly

Jim Cramer says smart investing is as simple as buying growth stocks when interest rates begin to fall.

Stock Market Today - 6/6: Dow Ends Slightly Higher as Treasury Yields Top 3%; Amazon Gains After 20-for-1 Split

Solid jobs and manufacturing data are prompting bets on a so-called 'Goldilocks' outcome for U.S. stocks as the Fed looks to tame inflation without choking-off growth.

Eli Lilly Stock Gains On Impressive Data From Jardiance Diabetes Drug Trial

"These five-year results ... showing empagliflozin was associated with a decreased risk of hospitalization for heart failure and for death, are encouraging data for adults with type 2 diabetes," said co-lead investigator Dr. Elisabetta Patorno.

Breaking News

Morgan Stanley Stock Leads Gains As Banks Boost Dividends After Fed Stress Tests

Morgan Stanley, Wells Fargo, Bank of America and Goldman Sachs will lift their quarterly dividend, while JPMorgan will hold its steady following last week's Fed stress tests.

Nike Stock Slides As As Margin Pressures, China Worries Offset Q4 Earnings Beat

"We think we're well positioned for growth in fiscal year 2023 ... having said that, we did take a cautious approach to Greater China," said CFO Matthew Friend.

Playtika Stock Slumps After Joffre Capital Takes 25.7% Stake Online Casino Gaming Group

Axios reported late Monday that tech buyout group Joffre Capital is seeking a majority stake in the online casino video game group.

Walgreens Stock Slides As Group Scraps Plan to Sell UK-based Boots

"As a result of market instability ... no third party has been able to make an offer that adequately reflects the high potential value of Boots," Walgreens said.